World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders (Q38123516)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 July 2013

Language	Label	Description	Also known as
English	World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders	scientific article published on 03 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders (English)

1 reference

Europe PubMed Central

29 August 2017

0 references

biological psychiatry

1 reference

based on heuristic

inferred from title

Hans-Jürgen Möller

6

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

29 August 2017

Peter C. Whybrow

4

object named as

Peter C Whybrow

1 reference

Europe PubMed Central

29 August 2017

Augustus John Rush

1 reference

ORCID Public Data File 2021

2

object named as

Andrea Pfennig

1 reference

Europe PubMed Central

29 August 2017

1

object named as

Michael Bauer

1 reference

Europe PubMed Central

29 August 2017

Emanuel Severus

3

object named as

Emanuel Severus

1 reference

Europe PubMed Central

29 August 2017

5

object named as

Jules Angst

1 reference

Europe PubMed Central

29 August 2017

author name string

World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders

7

1 reference

Europe PubMed Central

29 August 2017

publication date

3 July 2013

1 reference

Europe PubMed Central

29 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

29 August 2017

14

1 reference

Europe PubMed Central

29 August 2017

334-385

1 reference

Europe PubMed Central

29 August 2017

5

1 reference

Europe PubMed Central

29 August 2017

Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

High dose tranylcypromine therapy for refractory depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatment algorithms in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Meta-analytical studies on new antidepressants.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Suicide in psychiatric patients: risk and prevention

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A comparative study of nonspecific depressive symptoms and minor depression regarding functional impairment and associated characteristics in primary care

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Evidence that the SSRI dose response in treating major depression should be reassessed: a meta-analysis.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Guideline for the management of late-life depression in primary care.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

How to grade categories of evidence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatment of refractory depression with high-dose thyroxine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Thyroid hormone, neural tissue and mood modulation

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacogenomics and antidepressant drugs

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Affective Disorders and Suicide Risk: A Reexamination

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Relapse of depression after ECT: a review.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Exercise and the treatment of clinical depression in adults: recent findings and future directions

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatment of mood-congruent psychotic depression with imipramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Psychodynamic psychotherapy and clomipramine in the treatment of major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The use of psychotropic medications during breast-feeding

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Inhibition of GSK3beta is a common event in neuroprotection by different survival factors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A systematic review of treatments for refractory depression in older people

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressant use and risk of adverse outcomes in older people: population based cohort study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Side effects of electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Psychotherapy alone and combined with pharmacotherapy in the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Does electroconvulsive therapy damage brain cells?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Benefits from aerobic exercise in patients with major depression: a pilot study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A meta-analysis of the efficacy of cognitive therapy for depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Agomelatine treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Quetiapine augmentation of treatment-resistant depression: a comparison with lithium.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Risk factors of treatment resistance in major depression: association with bipolarity.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled st

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Diagnosis and definition of treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Switching to reboxetine: an efficacy and safety study in patients with major depressive disorder unresponsive to fluoxetine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The role of monoamine oxidase inhibitors in current psychiatric practice

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Convulsive therapy: a review of the first 55 years

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

DSM melancholic features are unreliable predictors of ECT response: a CORE publication.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Masked depression: its interrelations with somatization, hypochondriasis and conversion

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The initial field trials of DSM-5: new blooms and old thorns.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Tranylcypromine: new perspectives on an "old" drug

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Improvement of depression following transcranial magnetic stimulation.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Vagus nerve stimulation: a new tool for brain research and therapy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Direct comparison of total sleep deprivation and late partial sleep deprivation in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A meta-analysis of the effects of cognitive therapy in depressed patients

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The clinical meaning of refractory depression: a review for the clinician

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A rating scale for depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Can effects of antidepressants in patients with mild depression be considered as clinically significant?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Use of sertraline, paroxetine and fluvoxamine by nursing women

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Novel melatonin-based therapies: potential advances in the treatment of major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical importance of long-term antidepressant treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Cognitive Therapy and Pharmacotherapy for Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Impact of medical comorbid disease on antidepressant treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effects of cognitive therapy versus interpersonal psychotherapy in patients with major depressive disorder: a systematic review of randomized clinical trials with meta-analyses and trial sequential analyses

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressants and the risk of suicidal behaviors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Integration of Care: Integrating Psychotherapy and Pharmacotherapy to Improve Outcomes Among Patients With Mood Disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Neonate characteristics after maternal use of antidepressants in late pregnancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Managing depression and anxiety in the elderly patient.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Approaches to the management of depression in old age.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A double-blind comparison of the efficacy and safely of paroxetine and imipramine in the treatment of depression with dementia.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primar

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Residual symptoms at remission from depression: impact on long-term outcome.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

St. John's wort for depression: a meta-analysis of well-defined clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Genetic variants in FKBP5 affecting response to antidepressant drug treatment.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The course, morbidity, and costs of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Sleep deprivation therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A comparison of open treatment of seasonal major and minor depression with light therapy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

L-thyroxine augmentation of serotonergic antidepressants in female patients with refractory depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressant combination for major depression in incomplete responders--a systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Risperidone for treatment-refractory major depressive disorder: a randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical practice recommendations for depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The medical management of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Augmentation of standard depression therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Atypical antipsychotics in the treatment of affective symptoms: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Transcranial magnetic stimulation for depression and other psychiatric disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A regulatory Apologia--a review of placebo-controlled studies in regulatory submissions of new-generation antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatments of depression and the functional capacity to work.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Improving the chance of recovery from the short- and long-term consequences of depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Severe depression and antidepressants: focus on a pooled analysis of placebo-controlled studies on agomelatine

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Serial vagus nerve stimulation functional MRI in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Use of antidepressants during pregnancy and the risk of spontaneous abortion

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Neurodevelopment of children exposed in utero to antidepressant drugs

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Association between citalopram serum levels and clinical improvement of patients with major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of ECT in depression: a meta-analytic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Quality of life assessments in major depressive disorder: a review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Medication options in the treatment of treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Continuation drug therapy for major depressive episodes: how long should it be maintained?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effectiveness of electroconvulsive therapy in community settings

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Use of pattern analysis to identify true drug response. A replication

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Algorithm-guided treatment of depression reduces treatment costs--results from the randomized controlled German Algorithm Project (GAPII).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Challenges in the treatment of depression with psychotic features

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Staging methods for treatment resistant depression. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Optimal length of antidepressant trials in late-life depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Vagus nerve stimulation for depression: efficacy and safety in a European study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Citalopram treatment of social anxiety disorder with comorbid major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A novel augmentation strategy for treating resistant major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Suicide risk during antidepressant treatment.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatment resistant depression: methodological overview and operational criteria

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The pharmacological treatment of delusional depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Serotonin transporter gene and response to lithium augmentation in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Prevalence of depression and its treatment in an elderly population: the Cache County study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

High-dose selegiline in treatment-resistant older depressive patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A double-blind, randomized, fixed-dose trial of fluoxetine vs. amitriptyline in the treatment of major depression complicating Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Medication augmentation after the failure of SSRIs for depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Genes, environment, and individual differences in responding to treatment for depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Genetic predictors of response to antidepressants in the GENDEP project

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Trajectories of change in depression severity during treatment with antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Global burden of depressive disorders in the year 2000

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Chronobiological theories of nonseasonal affective disorders and their implications for treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A longitudinal population-based study of treated and untreated major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Prevalence and incidence studies of mood disorders: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The European Psychiatric Association (EPA) guidance on suicide treatment and prevention.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressants and sexual dysfunction.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Time course of response to antidepressants in late-life major depression: therapeutic implications

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Patterns of response to repeated total sleep deprivations in depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Sleep deprivation in depression: what do we know, where do we go?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Antidepressant treatment during breast-feeding

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

A systematic review of the mortality of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Bright light therapy stabilizes the antidepressant effect of partial sleep deprivation

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Prevalence of seasonal affective disorder at four latitudes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Clinical Benefits and Cost Effectiveness of Vagus Nerve Stimulation in a Long-term Treatment of Patients with Major Depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2013.804195

21 January 2018

Identifiers

10.3109/15622975.2013.804195

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38123516&oldid=1861317748"